London Picks INBS for New Drug Screening on Transport

Post by : Amit

Intelligent Bio Solutions Secures Landmark Contract in UK Public Transport Sector

In a significant development for workplace safety across the UK's capital, London’s public transport authority has officially selected Intelligent Bio Solutions Inc. (INBS) to provide its advanced, non-invasive drug screening technology. The decision aims to bolster safety standards across London's extensive transportation network, which includes buses, underground and overground trains, depots, and service centers.

The contract marks a major international expansion milestone for INBS, a US-based medical technology company known for its real-time, sweat-based biosensor systems. Their solution enables transport operators to identify on-duty substance impairment swiftly, discreetly, and with minimal disruption to operations.

This marks the first time such technology will be widely deployed across a major European transport network.

Sweating the Small Stuff: Drug Testing Without Needles or Labs

At the core of this agreement is INBS’s Intelligent Fingerprint Drug Screening System—a device that uses trace amounts of sweat collected from a person’s fingertip to deliver results in under 10 minutes. Unlike traditional urine or saliva testing, this method is fully portable, non-invasive, hygienic, and does not require gender-specific supervision or handling of biohazardous waste.

The decision to implement this new system comes after a competitive selection process where multiple safety and drug detection technologies were evaluated. According to INBS, the London transport agency opted for their system due to its accuracy, speed, ease of use, and minimal intrusion, especially in time-sensitive transportation environments.

Safer Commutes Through Proactive Workforce Monitoring

While the transport authority has not named specific employees or unions involved, officials confirmed the screening program will primarily focus on safety-critical roles. These include drivers, operators, depot maintenance staff, and individuals working in control rooms.

The goal is not to penalize but to identify and support individuals at risk before accidents or safety violations occur.

Transport for London (TfL), which oversees most of the capital’s public mobility, has previously faced criticism over its reactive approach to worker substance misuse. The rollout of real-time screening represents a policy shift toward proactive and preventive safety protocols.

“Public safety is non-negotiable,” said a spokesperson close to the initiative. “This screening system gives us real-time information to make better decisions while respecting the dignity and rights of our staff.”

INBS Riding a Wave of Global Demand

For Intelligent Bio Solutions, the contract adds to its growing portfolio of international clients across transportation, logistics, and industrial sectors. The company has already seen successful deployments in Australia, where similar technology is used in mining and construction.

Steven Marks, CEO of INBS, called the London deal “a breakthrough validation of our technology’s scalability and value in critical infrastructure.” He added, “Urban transport operators face unique challenges where time, safety, and operational fluidity intersect. Our system is designed to perform exactly at that junction.”

Marks also noted that INBS is in talks with other European cities considering pilot programs following London's announcement.

A Smart Fit in the Age of Surveillance Tech

The deployment aligns with a broader trend of digitization and real-time monitoring in public transport. From AI-based CCTV systems to predictive maintenance on escalators and trains, authorities are investing in tools that preempt problems before they escalate into service disruptions or safety incidents.

Drug screening had, until recently, remained largely in the domain of manual sampling and lab analysis. But as urban mobility systems become smarter and more autonomous, integrating health diagnostics at the point of work is seen as the next frontier.

“Real-time biometrics will eventually be as common as swipe cards or security cameras in transportation,” noted Dr. Anjali Rawat, a public safety analyst based in London. “INBS’s technology is part of that transformation.”

Worker Rights and Ethical Deployment

The rollout is not without its critics. Labour unions and privacy advocates have voiced concerns over potential misuse of biometric data and the risk of stigmatizing employees for medical or mental health conditions.

However, INBS clarified that the fingerprint drug testing system does not store personal biometric data, and results are anonymized at the point of collection unless linked to an authorized employee screening database. The system also avoids invasive data collection, unlike facial recognition or continuous health monitoring platforms.

London’s transport authorities have committed to deploying the technology in line with GDPR, union guidelines, and occupational health protocols.

Expansion Across the UK?

With London leading the way, other regional transport networks across the UK are reportedly watching the pilot closely. Authorities in Manchester, Birmingham, and Glasgow are believed to be in early discussions with INBS and similar providers.

If the rollout proves successful—reducing accidents, identifying patterns of workforce impairment, and improving response mechanisms—it could lead to a nationwide safety protocol shift for mass transit systems.

Transport safety expert Patrick Milton believes this is just the beginning. “The future of public safety lies in seamless, real-time systems that respect personal rights while delivering consistent oversight. INBS is offering just that.”

A Model for Other Sectors?

Beyond transport, the implications for INBS’s solution are vast. With industries such as aviation, shipping, rail freight, and manufacturing increasingly prioritizing on-the-job sobriety and mental alertness, sweat-based drug testing could emerge as a new standard.

What sets this system apart is its balance of precision, portability, and discretion—qualities that are critical in mission-critical, high-pressure jobs. Unlike blood testing or breathalyzers, which can be invasive or require trained technicians, this solution empowers safety officers to act quickly and fairly.

Redefining ‘Fit for Duty’

In many ways, London’s adoption of INBS’s drug screening system marks a broader redefinition of what it means to be “fit for duty” in modern public infrastructure. It’s not just about skills and schedules—it’s about state of mind and readiness, tracked not through speculation but smart, science-backed tools.

As cities grow more crowded and public systems grow more automated, such solutions will likely move from niche pilot projects to essential daily infrastructure. For now, London’s transport network has taken a bold first step—and the rest of Europe will be watching.

London, INBS, Drug Screening Transport